Literature DB >> 29936570

Rheumatoid factor isotype and Ro epitope distribution in primary Sjögren syndrome and rheumatoid arthritis with keratoconjunctivitis sicca.

Bob Meek1, Johannes C Kelder2, Anke M E Claessen3, Arend Jan van Houte3,4, Evert-Jan Ter Borg5.   

Abstract

Primary Sjögren syndrome (pS) is associated with autoantibodies such as rheumatoid factor (RF) and anti-nuclear antibodies such as anti-Ro (SS-A) and/or La (SS-B). Recent developments within autoimmune diagnostics allow quantitation of RF subclasses and anti-Ro epitopes. Will this refinement by autoimmune diagnostics help predicting development of extraglandular manifestations (EGM) in pS patients? A cohort of pS and rheumatoid arthritis (RA) patients with keratoconjunctivitis sicca (n = 35 and 16, resp) was included. Of the pS patients, 54% developed one or more EGM. Antibodies quantitated were IgM-RF, IgA-RF, IgG-RF, anti-Ro52, and anti-Ro60. Upon analysis of RF isotypes, pS patients generally displayed higher IgA-RF concentrations than RA patients (126 versus 49 U/ml, p = 0.015), while the dominant RF isotype in RA patients was IgM-RF (82.5 versus 38 U/ml, p = 0.012). No differences were observed regarding IgG-RF concentrations. In pS without/with EGM, the median RF IgM concentrations were similar, while RF IgA and IgG concentrations tended to be lower in pS patients with EGM > 1. Both Ro epitopes were strongly recognized by almost all pS patients, independent from EGM, while these antibodies were absent in RA patients. Primary Sjögren syndrome and RA patients have distinct serological profiles when analysing RF and Ro-specific antibodies. A longitudinal study of switched RF isotypes in pS patients is worthwhile from an immunological point of view, but its value is limited regarding identification of pS patients prone to developing EGM or RA patients prone to developing secondary sicca symptoms.

Entities:  

Keywords:  Extraglandular manifestations; Isotype; Rheumatoid arthritis; Rheumatoid factor; Ro; Sjögren

Mesh:

Substances:

Year:  2018        PMID: 29936570     DOI: 10.1007/s00296-018-4090-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  45 in total

1.  IgA-containing immune complexes in the circulation of patients with primary Sjögren's syndrome.

Authors:  B Bendaoud; Y L Pennec; A Lelong; J F Le Noac'h; G Magadur; J Jouquan; P Youinou
Journal:  J Autoimmun       Date:  1991-02       Impact factor: 7.094

Review 2.  The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome.

Authors:  P Szodoray; R Jonsson
Journal:  Scand J Immunol       Date:  2005-11       Impact factor: 3.487

3.  A pathogenetic role for IL-21 in primary Sjögren syndrome.

Authors:  Seung-Ki Kwok; Jennifer Lee; Di Yu; Kwi Young Kang; Mi-La Cho; Hae-Rim Kim; Ji Hyeon Ju; Sang-Heon Lee; Sung-Hwan Park; Ho-Youn Kim
Journal:  Nat Rev Rheumatol       Date:  2015-01-13       Impact factor: 20.543

4.  [Sjögren disease].

Authors:  E J ter Borg
Journal:  Ned Tijdschr Geneeskd       Date:  1994-09-03

5.  The clinical picture of primary Sjögren's syndrome: a retrospective study.

Authors:  N A Pavlidis; J Karsh; H M Moutsopoulos
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

6.  Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF.

Authors:  Peter Szodoray; Philip Alex; Malin V Jonsson; Nicholas Knowlton; Igor Dozmorov; Britt Nakken; Nicolas Delaleu; Roland Jonsson; Michael Centola
Journal:  Clin Immunol       Date:  2005-08-26       Impact factor: 3.969

Review 7.  The geoepidemiology of Sjögren's syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  Autoimmun Rev       Date:  2009-11-10       Impact factor: 9.754

Review 8.  Overlap connective tissue disease syndromes.

Authors:  Luca Iaccarino; Mariele Gatto; Silvano Bettio; Francesco Caso; Mariaelisa Rampudda; Margherita Zen; Anna Ghirardello; Leonardo Punzi; Andrea Doria
Journal:  Autoimmun Rev       Date:  2012-06-26       Impact factor: 9.754

9.  Nucleotide sequence analysis of rheumatoid factors and polyreactive antibodies derived from patients with rheumatoid arthritis reveals diverse use of VH and VL gene segments and extensive variability in CDR-3.

Authors:  V Pascual; K Victor; I Randen; K Thompson; M Steinitz; O Førre; S M Fu; J B Natvig; J D Capra
Journal:  Scand J Immunol       Date:  1992-08       Impact factor: 3.487

10.  Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.

Authors:  He Li; Tove Ragna Reksten; John A Ice; Jennifer A Kelly; Indra Adrianto; Astrid Rasmussen; Shaofeng Wang; Bo He; Kiely M Grundahl; Stuart B Glenn; Corinne Miceli-Richard; Simon Bowman; Sue Lester; Per Eriksson; Maija-Leena Eloranta; Johan G Brun; Lasse G Gøransson; Erna Harboe; Joel M Guthridge; Kenneth M Kaufman; Marika Kvarnström; Deborah S Cunninghame Graham; Ketan Patel; Adam J Adler; A Darise Farris; Michael T Brennan; James Chodosh; Rajaram Gopalakrishnan; Michael H Weisman; Swamy Venuturupalli; Daniel J Wallace; Kimberly S Hefner; Glen D Houston; Andrew J W Huang; Pamela J Hughes; David M Lewis; Lida Radfar; Evan S Vista; Contessa E Edgar; Michael D Rohrer; Donald U Stone; Timothy J Vyse; John B Harley; Patrick M Gaffney; Judith A James; Sean Turner; Ilias Alevizos; Juan-Manuel Anaya; Nelson L Rhodus; Barbara M Segal; Courtney G Montgomery; R Hal Scofield; Susan Kovats; Xavier Mariette; Lars Rönnblom; Torsten Witte; Maureen Rischmueller; Marie Wahren-Herlenius; Roald Omdal; Roland Jonsson; Wan-Fai Ng; Gunnel Nordmark; Christopher J Lessard; Kathy L Sivils
Journal:  PLoS Genet       Date:  2017-06-22       Impact factor: 5.917

View more
  3 in total

1.  IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren's syndrome.

Authors:  Maria Maślińska; Małgorzata Mańczak; Brygida Kwiatkowska; Vince Ramsperger; Long Shen; Lakshmanan Suresh
Journal:  Rheumatol Int       Date:  2021-01-26       Impact factor: 2.631

2.  Rheumatoid Factor: A Novel Determiner in Cancer History.

Authors:  Alessio Ugolini; Marianna Nuti
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

3.  Ocular Manifestations Related to Antibodies Positivity and Inflammatory Biomarkers in a Rheumatological Cohort.

Authors:  Carlos Cifuentes-González; Pilar Uribe-Reina; Juliana Reyes-Guanes; Juliana Muñoz-Ortiz; Paula Tatiana Muñoz-Vargas; William Rojas-Carabali; Dora Victoria Nova-Florián; Ana Sofía De-Los-Ríos; Rubén Dario Mantilla-Hernández; Alejandra de-la-Torre
Journal:  Clin Ophthalmol       Date:  2022-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.